Endogenous pain modulation after intensive muscle exertion and during experimentally induced muscle pain: conditioned pain modulation and offset analgesia

Organizational Data

DRKS-ID:
DRKS00014755
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2018-05-15
Last update in DRKS:
2019-10-31
Registration type:
Prospective

Acronym/abbreviation of the study

No Entry

URL of the study

No Entry

Brief summary in lay language

Studies in patients with chronic pain have shown that persistent pain leads to a change in the perception of painful and non-painful stimuli. The reason seems to be that people with chronic pain are no longer able to differentiate stimuli, i.e. perceive them differently depending on their intensity. There is occasional evidence that these mechanisms also occur in acute pain. We do not know yet whether this change in perception can be brought through benign muscle pain. In the current study the effect of a muscle exertion and a possibly resulting benign muscle pain ("muscle soreness") on various perception tests is to be examined.

Brief summary in scientific language

The lack of ability to perceive stimuli in a differentiated way, i.e. limited endogenous pain modulation, seems to be one of the main mechanisms for persistent pain syndromes or a possible explanation for the chronification of pain. It has not yet been clarified whether an altered pain modulation also occurs with acute pain, especially with benign muscle pain. Furthermore, it is known that pain modulation can be influenced, but it is not finally clarified whether changes can already be measured after a muscle exertion. The study will therefore investigate in healthy individuals whether measurable changes in pain modulations can be measured after a short training stimulus and whether these changes are influenced by the occurrence of benign muscle pain ("muscle soreness").

Health condition or problem studied

Free text:
Pain-free young adults
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
One-time isometric muscle load for the back extensor muscle (max. 4 minutes Biering-Sörensen test followed by concentric/eccentric muscle load for the back extensor (individual maximum number of repetitions)). The test is guided by a specialist physiotherapist who is not otherwise involved in the study.
Arm 2:
no intervention

Endpoints

Primary outcome:
Offset analgesia (thermode): 4 repeated measurements: Before the muscle load (1.), immediately afterwards (2.), 24 hours later (3.) and one week later (4.)
Secondary outcome:
Conditioned pain modulation (test stimulus: pressure pain thresholds; conditioning stimulus: ice water); Exercise-induced hypoalgesia (pressure pain threshold) 4 repeated measurements: Before the muscle load (1.), immediately afterwards (2.), 24 hours later (3.) and one week later (4.)

Study Design

Purpose:
Basic research/physiological study
Allocation:
Randomized controlled study
Control:
  • Control group receives no treatment
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Investigator/therapist

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
  • Poland
Number of study centers:
Multicenter study
Recruitment location(s):
  • University medical center Institut für Systemische Neurowissenschaften Hamburg
  • University medical center Klinik für Orthopädie und Unfallchirurgie Lübeck
  • University medical center The Jerzy Kukuczka Academy of Physical Education in Katowice Katowice

Recruitment period and number of participants

Planned study start date:
2018-06-01
Actual study start date:
2018-06-01
Planned study completion date:
No Entry
Actual Study Completion Date:
2018-09-03
Target Sample Size:
42
Final Sample Size:
42

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
45 Years
Additional Inclusion Criteria:
healthy (pain free) male or female Age: 18-45 years

Exclusion Criteria

chronic pain disorder, acute pain (including headache, toothache, muscle ache, etc.), orthopaedic or other diagnosis that does not allow to perform a training stimulus, Pregnancy, neurological, psychiatric or psychological illness migraine (if more than 1-2 attacks per year)

Addresses

Primary Sponsor

Address:
Universität zu Lübeck
Prof. Dr. Kerstin Luedtke
Ratzeburger Allee 160
23562 Lübeck
Germany
Telephone:
Tel + 49 451 3101 8541
Fax:
Fax + 49 451 3101 8544
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uni-luebeck.de/
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Universität zu Lübeck
M.Sc. Tibor Szikszay
Ratzeburger Allee 160
23562 Lübeck
Germany
Telephone:
Tel + 49 451 3101 8541
Fax:
Fax + 49 451 3101 8544
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uni-luebeck.de

Contact for Public Queries

Address:
Universität zu Lübeck
M.Sc. Tibor Szikszay
Ratzeburger Allee 160
23562 Lübeck
Germany
Telephone:
Tel + 49 451 3101 8541
Fax:
Fax + 49 451 3101 8544
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uni-luebeck.de

Principal Investigator

Address:
Universität zu Lübeck
M.Sc. Tibor Szikszay
Ratzeburger Allee 160
23562 Lübeck
Germany
Telephone:
Tel + 49 451 3101 8541
Fax:
Fax + 49 451 3101 8544
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uni-luebeck.de

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Universität zu Lübeck
Ratzeburger Allee 160
23562 Lübeck
Germany
Telephone:
Tel + 49 451 3101 8541
Fax:
Fax + 49 451 3101 8544
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.uni-luebeck.de/

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Med. Fakultät der Universität zu Lübeck
Ratzeburger Allee 160
23538 Lübeck
Germany
Telephone:
+49-451-5004639
Fax:
+49-451-5003026
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2017-12-22
Ethics committee number:
18-006
Vote of the Ethics Committee:
Approved
Date of the vote:
2018-02-01

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry